ArticleFrontiers in endocrinology2026
Acupuncture modulates extracellular vesicle-miRNA-HMOX1 axis to inhibit ferroptosis in polycystic ovary syndrome: integrating machine learning,
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Acupuncture therapy shows promise for polycystic ovary syndrome (PCOS), but its molecular mechanisms remain unclear. This study investigates whether acupuncture alleviates PCOS by regulating granulosa cell (GC) ferroptosis via extracellular vesicles (EVs). Methods: Bioinformatic analysis of KGN cell transcriptome data identified heme oxygenase-1 (HMOX1) as a key candidate. Its role was validated in a PCOS rat model and GCs using RT-qPCR, western blot, and immunohistochemistry. Ferroptosis was assessed via malondialdehyde (MDA), glutathione (GSH), and ferroptosis-related proteins (GPX4, FTH1, SLC7A11, NCOA4). HMOX1 gain/loss-of-function, rescue experiments (ferrostatin-1), and transmission electron microscopy defined its function. PCOS rats received acupuncture for 4 weeks; ovarian function and ferroptosis markers were analyzed. EVs from follicular fluid were characterized, and miRNA candidates targeting HMOX1 were screened. The EV-miRNA mechanism was tested via co-culture and inhibition assays. Results: HMOX1 was upregulated in PCOS. Its overexpression induced ferroptosis and impaired GC proliferation, reversible by ferrostatin-1. Acupuncture improved ovarian histology and oocyte maturation, concurrently normalizing HMOX1 and ferroptosis markers. It specifically enriched miR-873-5p in EVs. These EVs delivered miR-873-5p to GCs, downregulating HMOX1 and alleviating ferroptosis, an effect blocked by miR-873-5p inhibition. Conclusions: Acupuncture mitigates PCOS by promoting EV-mediated transfer of miR-873-5p, which targets HMOX1 to inhibit GC ferroptosis and restore ovarian function. This identifies a novel acupuncture-EV-miRNA-HMOX1-ferroptosis axis as a therapeutic mechanism for PCOS.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.